HiFiBio Therapeutics, an emerging multinational biotherapeutics company based in France, has raised $67 million in its Series C funding round led by new investor IDG Capital with participation from existing shareholder Sequoia Capital China.
Other investors – both new and existing – who joined the funding round include VI Ventures, Legend Stars Capital, LYFE Capital, Delian Capital, Hanne Capital, and Kite, the company said in a statement.
